None listed
Conditions
Interventions
None listed
Sponsors
Korea Centers for Disease Control and Prevention
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria 1) Patients were histologically verified amyloidosis deposition at least one or more organ Or Patients were reasonable to be diagnosed a cardiac amyloidosis on echocardiography or heart magnetic resonance imaging increasing with immunoglobulin light chain in serum or urine. - Echocardiography results: mean left ventricular wall thickness >12mm and patients who have no other cardiovascular disease such as valve disease or hypertension - Heart magnetic resonance imaging results: Gadolinium delayed enhancement in a wide range of endocardium 2) Patients who were aged 20 years or older 3) Patients who were obtained consent form to participate the research 4) Patients who were written consent form to genetic and biochemical test for research purpose using bone marrow, peripheral blood and tissue obtained for diagnostic purpose
Exclusion criteria
Exclusion criteria: Exclusion criteria Patients who do not agree with this study and biochemical and genetic examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| motality at anytime | — |
Secondary
| Measure | Time frame |
|---|---|
| treatment response | — |
Countries
Korea, Republic of
Contacts
Public ContactGa Yeon Lee
Sungkyunkwan University
Outcome results
None listed